Contraceptive Technology Update – April 1, 2004
April 1, 2004
View Issues
-
Overcome the stigma of herpes with positive messages for patients
Strides are being made when it comes to herpes. New treatments are emerging, and an advanced clinical trial of a potential herpes vaccine now is under way. -
Bulletin: FDA delays decision on Plan B
The decision to move the levonorgestrel emergency contraceptive pill Plan B (Barr Laboratories, Pomona, NY) to over-the-counter status has been delayed by the Food and Drug Administration. -
Teens face obstacles when obtaining EC
The adolescent in your exam room just told you she had unprotected sex over the weekend. When you ask her if she used emergency contraception (EC), she says she didnt know where to get a prescription because the clinic was closed. -
Is male contraceptive on horizon? Trials under way
Look for new developments this year when it comes to male contraception. While it may be some time before an actual product reaches the market shelves, scientists are gaining ground in the development of possible forms of birth control for men. -
Polycystic ovary syndrome gets redefined diagnosis
A quick check of your next patient chart shows a woman with irregular or absent ovulation and elevated levels of androgenic hormones. Whats your initial diagnosis? -
Break down teen barriers with direct provision
Direct distribution of birth control may be an effective strategy for school-based clinics wishing to remove barriers to contraceptive access, according to research findings from Minnesota public health officials. -
Contraceptive Technology Reports: An Analysis of the Today Sponge — Prepare for Its Return to the U.S.
The Today contraceptive sponge awaits the results of a Food and Drug Administration (FDA) review to return to the shelves in the United States. After being approved by the FDA in 1983, the sponge achieved considerable popularity before production was discontinued in 1995. Since then, Allendale (NJ) Pharmaceuticals has purchased rights to the Today sponge and has been working to bring the product back to the United States.